Type2diabetes: Clinical Trials

1 trial for Type2diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Type2diabetes: new trials by email Literature Review of Type2diabetes trials Research Report on Type2diabetes

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes
Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg metformin plus 15mg pioglitazone) - Type2diabetes, Insulin Resistance
Phase 3UnknownNanjing First Hospital, Nanjing Medical University602022-11-012022-10-24

Narrower conditions

Insulin Resistance (1)

Broader conditions

Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Metformin (1)  ·  Pioglitazone (1)  ·  dapagliflozin (1)

Sponsors

Nanjing First Hospital, Nanjing Medical University (1)